FCM
GH icon

Fourpath Capital Management’s Guardant Health GH Stock Holding History

Fourpath Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,842
Closed -$284K – 162
2021
Q4 		$284K Buy
+2,842
New +$294K 0.11% 126

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fourpath Capital Management's GH Position: Q1 2022 in Review

Fourpath Capital Management sold out of Guardant Health (GH) in Q1 2022, closing a stake of 2,842 shares — an estimated $284K sold.

Fourpath Capital Management first reported a position in GH in Q4 2021 and held it in 1 quarter. The position peaked at $284K in Q4 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Fourpath Capital Management reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Fourpath Capital Management sold 2,842 Guardant Health shares in Q1 2022, an estimated $284K.
  • Fourpath Capital Management first reported a position in Guardant Health in Q4 2021 and held it in 1 quarter.
  • Fourpath Capital Management's Guardant Health position peaked at $284K in Q4 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Fourpath Capital Management's 13F filing for Q1 2022, filed 14 Apr 2022.